Physiological and pathophysiological roles of eicosanoids in the microcirculation

Cardiovascular Research

Volumn 32, Issue 4, 1996, Pages 720-732

  Gerritsen, Mary E ^a  

^a BAYER CORPORATION   (United States)

Author keywords

Angiogenesis; Aspirin; Cyclooxygenase; Endothelium; Indomethacin; Microcirculation; Nitric oxide; Prostaglandin

Indexed keywords

ACETYLSALICYLIC ACID; ICOSANOID; INDOMETACIN; NITRIC OXIDE; PROSTAGLANDIN;

ANGIOGENESIS; HUMAN; LEUKOCYTE ADHERENCE; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; THROMBOCYTE AGGREGATION;

ANIMALS; BLOOD COAGULATION; CAPILLARY PERMEABILITY; EICOSANOIDS; ENDOTHELIUM, VASCULAR; FIBRINOLYSIS; HUMANS; MICROCIRCULATION; NEOVASCULARIZATION, PHYSIOLOGIC; NEUTROPHIL ACTIVATION; RATS; VASCULAR RESISTANCE;

EID: 0030270063     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/0008-6363(96)00072-7     Document Type: Review

References (133)

1. [1] Brendel K, Meezan E, Carlson EC. Isolated brain microvessels: a purified, metabolically active preparation from bovine cerebral cortex. Science 1974;185:953-955.
2. [2] Gerritsen ME, Printz MP. Sites of prostaglandin synthesis in the bovine heart and isolation of coronary microvessels. Circ Res 1981;49:1159-1171.
3. [3] Meezan E, Brendel K, Carlson EC. Isolation of a purified preparation of metabolically active retinal blood vessels. Nature 1974;251:65-67.
4. [4] Gerritsen ME, Parks TP, Printz MP. Prostaglandin endoperoxide metabolism by bovine cerebral microvessels. Biochim Biophys Acta 1980;619:196-206.
5. 2. Stroke 1984;15:717-722.
6. [6] Gerritsen ME, Cheli CD. Arachidonic acid and prostaglandin endoperoxide metabolism in isolated rabbit and coronary microvessels and isolated and cultivated coronary microvessel endothelial cells. J Clin Invest 1983;72:1658-1671.
7. 2 is not a major metabolite of arachidonate acid in cultured endothelial cells from human foreskin microvessels. J Clin Invest 1984;74:914-919.
8. 2 is not a major prostanoid produced by cultured rabbit renal microvascular endothelial cells. Am J Physiol 1989;256:F266-F273.
9. [9] Carley WW, Niedbala MJ, Gerritsen ME. Isolation, cultivation and partial characterization of microvascular endothelium derived from human lung. Am J Respir Cell Mol Biol 1992;7:620-630.
10. [10] Szczepanski A, Moatter TM, Carley WW, Gerritsen ME. Induction of cyclooxygenase II in human synovial microvessel endothelial cells by IL-1. Inhibition by glucocorticoids. Arth Rheum 1994;37:495-503.
11. [11] Nitta K, Uchida K, Yumura W, Nihei H. Characterization of the glomerular endothelial cell in culture. Jpn J Nephrol 1993;35:887-891.
12. [12] Gerritsen ME, Printz MP. PGD synthase in microvessels from the rat cerebral cortex. Prostaglandins 1981;22:553-557.
13. [13] Stanimirovic DB, Bacic F, Uematsu S, Spatz M. Profile of prostaglandins induced by endothelin-1 in human brain capillary endothelium. Neurochem Int 1993;23:385-393.
14. [14] Spatz M, Stanimirovic DB, Bacic F, Uematsu S, BJ, McCarron RM. Peptidergic induction of endothelin 1 and prostanoid secretion in human cerebromicrovascular endothelium. In: Drewes LR, Betz AL, eds. Frontiers in Cerebral Vascular Biology: Transport and its Regulation. New York: Plenum Press, 1993:165-170.
15. [15] DeWitt DL, Smith WL. Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence. Proc Natl Acad Sci USA 1988;85:1412-1416.
16. [16] Hemler M, Lands WEM. Purification of the cyclooxygenase that forms prostaglandins. Demonstration of two forms of the holoenzyme. J Biol Chem 1976;251:5575-5581.
17. [17] Yokoyama C, Tanabe T. Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme. Biochem Biophys Res Commun 1989;165:888-894.
18. [18] Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 1991;266:12866-12872.
19. [19] Xie W, Chipman JG, Robertson DL, Erikson RL, Simmons DL. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 1991;88:2692-2696.
20. [20] Hla T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 1992;89:7384-7388.
21. [21] Sirois J, Richards J. Characterization and regulation of the promoter of the rat prostaglandin endoperoxide synthase gene in granulosa cells. J Biol Chem 1992;267:6382-6388.
22. [22] Futaki N, Yoshikawa Y, Hamasaka I, Arai S, Higuchi H, Hzuka H, Otomo S. NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects which causes minimal stomach lesions. Gen Pharmacol 1993;24:105-110.
23. [23] Otto JC, De Witt DL, Smith WL. N-glycosylation of prostaglandin endoperoxide synthases-1 and -2 and their orientation in the endoplasmic reticulum. J Biol Chem 1993;268:18234-18242.
24. [24] Xie W, Merril JR, Bradshaw WS, Simmons DL. Arch Biochem Biophys 1993;300:247-252.
25. [25] Morita I, Schindler M, Regier MK, Otto JC, Hori T, De Witt DL, Smith WL. Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2. J Biol Chem 1995;270:10902-10908.
26. [26] Kraemer SA, Meade EA, De Witt DL. Prostaglandin endoperoxide synthase gene structure - identification of the transcriptional start site and 5′ flanking sequences. Arch Biochem Biophys 1992;293:391-400.
27. [27] Ristimaki A, Garfinkel S, Wessendorf J, Maciag T, Hla T. Induction of cyclooxygenase by interleukin-1 α. Evidence for post-transcriptional regulation. J Biol Chem 1994;269:11769-11775.
28. [28] Moatter T, Gerritsen ME. Fibroblast growth factor upregulates PGG/H synthase in rabbit microvascular endothelial cells by a glucocorticoid independent mechanism. J Cell Physiol 1992;151:571-578.
29. [29] Weksler, BB. Heparin and acidic fibroblast growth factor interact to decrease prostacyclin synthesis in human endothelial cells by affecting both prostaglandin H synthase and prostacyclin synthase. J Cell Physiol 1990;142:514-522.
30. [30] Hla T, Maciag T. Cyclooxygenase gene expression is down-regulated by heparin-binding (acidic fibroblast) growth factor-1 in human endothelial cells. J Biol Chem 1991;35:24059-24063.
31. [31] Sano H, Hla T, Maier JAM, Crofford LJ, Case JP, Maciag T, Wilder RL. In vivo Cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. J Clin Invest 1992;89:97-108.
32. [32] Kujubu DA, Herschman HR. Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene. J Biol Chem 1992;267:7991-7994.
33. [33] O'Banion MK, Winn VD, Young DA. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc Natl Acad Sci USA 1991;89:4888-4892.
34. [34] Szczepanski A, Moatter TM, Carley WW, Gerritsen ME. Induction of Cyclooxygenase II in human synovial endothelial cells by IL-1. Inhibition by glucocorticoids. Arth Rheum 1994;37:495-503.
35. 2 mRNA in lung fibroblasts and endothelial cells in culture. Biochem Biophys Res Commun 1993;197:1465-1474.
36. [36] Hara S, Miyata A, Yokoyama C, Inoue H, Brugger R, Lottspeich F, Ullrich V, Tanabe T. Isolation and cloning of prostacyclin synthase from bovine endothelial cells. J Biol Chem 1994;269:19897-19903.
37. [37] Nagata A, Suzuki Y, Igarashi M, Eguchi N, Toh H, Urade Y, Hayaishi O. Human brain prostaglandin D synthase has been evolutionarily differentiated from lipophylic-ligand carrier proteins. Proc Natl Acad Sci USA 1991;88:4020-4024.
38. [38] Funk CD. Molecular biology in the eicosanoid field. Prog Nucleic Acid Res Mol Biol 1993;45:67-98.
39. [39] Yokoyama C, Miyata A, Ihara H, Ullrich V, Tanabe T. Molecular cloning of human platelet thromboxane synthase. Biochem Biophys Res Commun 1991;178:1479-1482.
40. [40] Wetzka B, Schafer W, Kommos F, Bettendorf H, Nusing R, Breckwoldt M, Sahradnik HP. Immunohistochemical localization of thromboxane synthase in human intrauterine tissues. Placenta 1994;15:389-398.
41. [41] Nusing R, Lesch R, Ullrich V. Immunohistochemical localization of thromboxane synthase in human tissues. Eicosanoids 1990;3:53-58.
42. 4 synthesized by polymorphonuclear leukocytes. J Biol Chem 1986;261:16466-16472.
43. [43] Brady HR, Serhan CN. Adhesion promotes transcellular leukotriene biosynthesis during neutrophil-glomerular endothelial cell interactions: inhibition by antibodies against CD18 and L-selectin. Biochem Biophys Res Commum 1992;186:1307-1314.
44. [44] Hamberg M, Samuelson B. Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proc Natl Acad Sci USA 1974;71:3400-3404.
45. [45] Baba A, Sakuma S, Okamoto H, Inoue T, Iwata H. Calcium induces translocation of 12-lipoxygenase in rat platelets. J Biol Chem 1989;264:15790-15795.
46. [46] Funk C, Funk L, Fitzgerald G, Samuelsson B. Characterization of human 12-lipoxygenase genes. Proc Natl Acad Sci USA 1992;89:3962-3966.
47. [47] Nishiyama M, Watanabe T, Ueda N, Tsukamoto H, Watanabe K. Arachidonate 12-lipoxygenase is localized in neurons, glial cells and endothelial cells of the canine brain. J Histochem Cytochem 1993;41:111-117.
48. [48] Shannon VR, Crouch EC, Takahashi Y, Ueda N, Yamamoto S, Holtzman MJ. Related expression of 12-and 15-lipoxygenases in animal and human lung tissue. Am J Physiol 1991;261:L399-L405.
49. [49] Gorman RR, Oglesby T, Bundy GL, Hopkins NK. Evidence for 15-HETE synthesis by human umbilical vein endothelial cells. Circulation 1985;72:708-712.
50. [50] Meade E, Smith W, De Witt D. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1993;268:6610-6614.
51. [51] Lu AYH, West SB. Multiplicity of mammalian microsomal cytochromes P-450. Pharm Rev 1980;31:277-295.
52. [52] Fitzpatrick FA, Murphy RC. Cytochrome P-450 metabolism of arachidonic acid: formation and biological actions of "epoxygenase"-derived eicosanoids. Pharm Rev 1989;40:229-241.
53. [53] Capdevila JH, Falck JR, Estabrook RW. Cytochrome P450 and the arachidonic acid cascade. FASEB J 1992;6:731-736.
54. [54] Harder D, Campbell W, Roman R. Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone. J Vasc Res 1995;32:79-92.
55. [55] Pritchard Jr K, Wong P, Stemerman M. Atherogenic concentrations of low-density lipoprotein enhance endothelial cell generation of epoxyeicosatrienoic products. Am J Pathol 1990;136:1383-1391.
56. [56] Bauersachs J, Hecker M, Busse R. Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation. Br J Pharmacol 1994;113:1548-1553.
57. [57] Pettitt TR, Rowley AF, Barrow SE, Mallet AI, Secombes CJ. Synthesis of lipoxins and other lipoxygenase products by macrophages from the rainbow trout, Oncorhynchus mykiss. J Biol Chem 1991;266:8720-8726.
58. [58] Serhan CN. Cell-cell interactions in the generation of eicosanoids: charting the routes and products of transcellular biosynthesis. J Lab Clin Med 1993;121:372-374.
59. [59] Serhan CN. Lipoxin biosynthesis and its impact in inflammatory and vascular events. Biochim Biophys Acta 1994;1212:1-25.
60. [60] Morrow JD, Minton T, Mukundan CR, et al. Free radical-induced generation of isoprostanes in vivo. Evidence for the formation of D-ring and E-ring isoprostanes. J Biol Chem 1994;269:4317-4326.
61. 2α. J Biol Chem 1995;270:9800-9808.
62. [62] Narumiya S. Prostanoid receptors. Structure, function and distribution. Ann NY Acad Sci 1994;744:126-138.
63. [63] Coleman RA, Smith WL, Narumiya S. VIII. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharm Rev 1994;46:205-229.
64. [64] Gorman RR, Bunting S, Miller OV. Modulation of human platelet adenylate cyclase by prostacyclin (PGX). Prostaglandins 1977;13:377-388.
65. [65] Tateson JE, Moncada S, Vane JR. Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets. Prostaglandins 1977;13:389-397.
66. [66] Radomski MW, Palmer RM, Moncada S. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol 1987;92:639-646.
67. [67] De Nucci G, Gryglewski R, Warner T, Vane J. Receptor mediated release of endothelium derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled. Proc Natl Acad Sci USA 1988;85:2334-2338.
68. [68] Fostermann V, Warmuth G, Dudek C, Alheid V. Formation and functional importance of endothelium derived relaxing factor (EDRF) and prostaglandins in the microcirculation. Z Kardiol 1989;78:85-91.
69. 1 and nitroglycerin. Circ Res 1989;65:796-804.
70. [70] Kaplan K, Mather T, De Marco L, Solomon S. Effect of fibrin on endothelial cell production of prostacyclin and tissue plasminogen activator. Atherosclerosis 1989;9:43-49.
71. [71] Williams TJ, Peck MJ. Role of prostaglandin mediated vasodilation in inflammation. Nature 1977;270:530-531.
72. 2 and the vascular changes of inflammation. Br J Pharmacol 1979;65:517-524.
73. 4: a mediator of vascular permeability. Br J Pharmacol 1981;72:483-486.
74. 2 in the rat cremaster muscle. Adv Prost Thromb Leukotriene Res 1980;7:719-722.
75. [75] Warren JB, Wilson AJ, Loi RK, Coughlan ML. Opposing roles of cyclic AMP in the vascular control of edema formation. FASEB J 1993;7:1394-1400.
76. [76] Messina EJ, Weiner R, Kaley G. Prostaglandins and local circulatory control. Fed Proc 1976;355:803-813.
77. [77] Prins BA, Hu R-M, Nazario B, Pedram A, Frank JL, Weber MA, Levin ER. Prostaglandin E, and prostacyclin inhibit the production and secretion of endothelin from cultured endothelial cells. J Biol Chem 1994;269:11938-11944.
78. [78] Hedqvist P, Raud J, Dahlen S-E. Microvascular actions of eicosanoids in the hamster cheek pouch. Adv Prost Thromb Leukotriene Res 1990;20:153-160.
79. [79] Arfors KE, Lundberg C, Lindbom L, Lundberg K, Beatty PG, Harlan JM. A monoclonal antibody to the membrane complex CD18 inhibits polymorphonuclear accumulation and plasma leakage in vivo. Blood 1987;69:338-340.
80. 4 induces extravasation and migration of polymorphonuclear leukocytes. Acta Physiol Scand 1982;116:105-108.
81. 4: lack of structural injury to the endothelium. Tissue Cell 1986;18:1-12.
82. 4, platelet activating factor and substance P as mediators of acute inflammation. Pathol Immunopathol Res 1987;6:190-206.
83. [83] Dahlen SE, Bjork J, Hedqvist P, Arfors K, Hammerstrom S, Lindgren J, Samuelsson B. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci USA 1981;78:3887-3891.
84. 4 induced inflammation in the hamster cheek pouch. Acta Physiol Scand 1989;137:571-572.
85. 4 include lung strip contraction and dilation of arterioles in vivo. Acta Physiol Scand 1987;130:643-648.
86. [86] Papayianni A, Serhan CN, Brady HR. Lipoxins inhibit adhesion of neutrophils and endothelial cells mediated by P-selectin and B2 integrins through distinct actions on neutrophils and endothelial cells. J Am Soc Nephrol 1994;5:792.
87. 4: a novel anti-inflammatory molecule? Thorax 1995;50:111.
88. 4 and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. Clin Sci 1989;77:195.
89. 4 inhibits phosphoinositide hydrolysis in human neutrophils. Biochem Biophys Res Commun 1990;167:1022.
90. 4 on chemotaxis and degranulation of human eosinophils stimulated by platelet activating factor and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. Allergy 1994;49:230.
91. [91] Smith WL, Meade EA, De Witt DL. Pharmacology of prostaglandin endoperoxide synthase isozymes-1 and -2. Ann NY Acad Sci 1994;744:136-142.
92. [92] Holtzman MJ, Turk J, Shornick LP. Identification of a pharmacologically distinct prostaglandin H synthase in cultured epithelial cells. J Biol Chem 1992;267:21438.
93. [93] Masferrar J, Rimarachin JA. Gerritsen ME, Falck JR, Yadagiri P, Dunn MW, Schwartzman ML. 12(R)-Hydroxyeicosatrienoic acid, a potent chemotactic and angiogenic factor produced by the cornea. Exp Eye Res 1991;52:417-423.
94. 4 stimulation of matrix metalloproteinase-dependent migration of human T cells across a model basement membrane. FASEB J 1995;9:A853.
95. 2. J Immunol 1994;152:5703-5713.
96. [96] Kuo L, Davis MJ, Chilian WM. Endothelium-dependent, flow-induced dilation of isolated coronary arterioles. Am J Physiol 1990;259:860-866.
97. [97] Koller A, Kaley G. Endothelial regulation of wall shear stress and blood flow in skeletal muscle microcirculation. Am J Physiol 1991;260:H862-H868.
98. [98] Koller A, Kaley G. Prostaglandins mediate arteriolar dilation to increased blood flow velocity in skeletal muscle microcirculation. Circ Res 1990;67:529-534.
99. [99] Kuo L, Chilian WM, Davis MJ. Interaction of pressure-and flow-induced responses in porcine coronary resistance vessels. Am J Physiol 1991;261:H1706-H1715.
100. [100] Katusic ZS, Shepherd JT, Vanhoutte PM. Endothelium-dependent contraction to stretch in canine basilar arteries. Am J Physiol 1987;252:H671-H673.
101. [101] Falcone JC, Davis MJ, Meininger GA. Endothelial independence of the myogenic response in isolated skeletal muscle arterioles. Am J Physiol 1991;260:H130-H135.
102. [102] Hwa JJ, Bevan JA. Stretch-dependent (myogenic) tone in rabbit ear resistance arterioles. Am J Physiol 1986;250:H87-H95.
103. [103] Kulik TJ, Evans JN, Gamble WJ. Stretch-induced reaction in pulmonary arteries. Am J Physiol 1988;255:H391-H398.
104. [104] Hill MA, Davis MJ, Meininger GA. Cyclooxygenase inhibition potentiates myogenic activity in skeletal muscle arterioles. Am J Physiol 1990;258:H127-H133.
105. [105] Huang A, Sun D, Koller A. Endothelial dysfunction augments myogenic arteriolar constriction in hypertension. Hypertension 1993;22:913-921.
106. [106] Koller A, Huang A. Impaired nitric oxide-mediated flow-induced dilation in arterioles of spontaneously hypertensive rats. Circ Res 1994;74:416-421.
107. [107] Stolz RA, Conners MS, Gerritsen ME, Abraham NG, Schwartzman ML. Direct stimulation of limbal microvessel endothelial cell proliferation and capillary formation in vitro by a corneal derived eicosanoid. Am J Pathol 1996;148:129-139.
108. 1 and copper in angiogenesis. J Natl Cancer Inst 1982;69:475-482.
109. [109] Ben-Ezra D. Neovasculogenic ability of prostaglandins, growth factors and synthetic chemoattractants. Am J Ophthalmol 1978;86:455-461.
110. 2 and angiogenesis. Proc Soc Exp Biol Med 1983;172:214-218.
111. [111] Folkman J, Klagsburn M. Angiogenic factors. Science 1987;235:442-447.
112. [112] Moatter TM, Gerritsen ME. Acidic fibroblast growth factor induction of cyclooxygenase II in rabbit cardiac muscle microvessel endothelial cells: mediation by protein kinase C. Microcirculation 1994;1:79-88.
113. [113] Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;299:373-376.
114. [114] Lamontagne D, Konig A, Bassenge E, Busse R. Prostacyclin and nitric oxide contribute to the vasodilator action of acetylcholine and bradykinin in the intact rabbit coronary bed. J Cardiovasc Pharmacol 1992;20:652-657.
115. [115] Kilbourn RG, Belloni P. Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1 or endotoxin. J Natl Cancer Inst 1990;82:772-776.
116. [116] Marumo T, Nakaki T. Adachi H, Esumi H, Suzuki H, Saruta T, Kato R. Nitric oxide synthase mRNA in endothelial cells: synergistic induction by interferon gamma, tumor necrosis factor alpha and lipopolysaccharide and inhibition by dexamethasone. Jpn J Pharmacol 1993;63:327.
117. [117] Akarasereenont P, Mitchell JA, Bakhle YS, Thiemermann C, Vane JR. Comparison of the induction of cyclooxygenase and nitric oxide synthase by endotoxin in endothelial cells and macrophages. Eur J Pharmacol 1995;273:121-128.
118. [118] Radomski MW, Palmer RM, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 1990;87:10043-10047.
119. [119] Salvemini D, Settle SL, Masferrer JL, Seibert K, Currie MG, Needleman P. Regulation of prostaglandin production by nitric oxide: an in vivo analysis. Br J Pharmacol 1995;114:1171-1178.
120. [120] Sautebin L, DiRosa M. Nitric oxide modulates prostacyclin biosynthesis in the lung of endotoxin treated rats. Eur J Pharmacol 1994;262:193-196.
121. [121] Salvemini D, Seibert K, Masferrer JL, Misko TP, Currie MG, Needleman P. Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J Clin Invest 1994;93:1940-1947.
122. [122] DeCaterina R, Dorso C, Tack-Goldman K, Weksler B. Nitrates and endothelial prostacyclin production. Circulation 1985;71:176-182.
123. [123] Levin R, Jaffe E, Weksler B, Tack-Goldman K. Nitroglycerin stimulates synthesis of prostacyclin by cultured endothelial cells. J Clin Invest 1981;67:762-769.
124. [124] Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 1993;90:7240-7244.
125. [125] Davidge ST, Baker PN, Laughlin MK, Roberts JM. Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase. Circ Res 1995;77:274-283.
126. [126] McCall TB. Boughton-Smith NK, Palmer RMJ, Whittle BJR, Moncada S. Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with Superoxide anion. Biochem J 1989;261:293-296.
127. 2 negatively modulates induction of nitric oxide synthase by interleukin 1. Proc Natl Acad Sci USA 1994;91:12168-12172.
128. [128] Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992;6:3051-3064.
129. [129] Ignarro LJ. Signal transduction mechanisms involving nitric oxide. Biochem Pharmacol 1991;41:485-490.
130. [130] Kalyanaranman B, Mason RP, Tainer B, Eling TE. The free radical formed during the hydroperoxide-mediated deactivation of ram seminal vesicles is hemoprotein-derived. J Biol Chem 1982;257:4764-4768.
131. [131] Chen X, Sheller J, Johnson E, Funk C. Role of leukotrienes revealed by targeted disruption of the 5′-lipoxygenase gene. Nature 1994;372:179-182.
132. [132] Langenbach R. MSG, Tiano H, Loftin C, Ghanayem B, Chulada P, Mahler J. Lee C, Goulding E, Kluckman KD, Kim H, Smithies O. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 1996;83:483-492.
133. [133] Morham S, Langenbach R, Loftin C, Tiano H, Vouloumanos N, Jennelte J, Mahler J, Kluckman KD, Ledford A, Lee C, Smithies O. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 1996;83:493-501.